Internal restructuring
Location of affected unit(s)
Bologna, Milan, Alanno (Pescara), Sermoneta (Latina), Pomezia (Roma).
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

476 jobs
Number of planned job losses
Job loss
Announcement Date
6 September 2017
Employment effect (start)
14 November 2017
Foreseen end date
14 March 2018


Pharmaceutical firm Alfasigma announced 476 dismissals across its Italian sites, namely the offices in Bologna and Milan, and the plants in Alanno (Pescara), Sermoneta (Latina), Pomezia (Roma).

With a total employee base of 1,696, the company is one of the largest pharmaceutical firms in Italy. It was established following a fusion between three large firms in August 2017.

The decision of cutting the jobs is attributed to negative market trends and overlap of job functions due to the recent merger.

Redundancies should affect mainly sales representatives and administrative personnel (456) plus 20 managers.

Unions are taking part in the collective dismissal procedure and wish to influence the outcome thereof, deeming the decision of the management not inline with the company’s industrial plan. In the meantime workers are issuing strikes and demonstrations.


  • 6 September 2017: La Reoubblica
  • 20 September 2017: Il Caffè
  • 28 September 2017: Rassegna Sindacale


Eurofound (2017), Alfasigma, Internal restructuring in Italy, factsheet number 92207, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/92207.